Following the same experimental trail, Chen et al. used CRISPR/Cas9 gene-editing technology to prove that global microRNA depletion, induced by knocking out DICER1, suppresses tumor angiogenesis in a non-small cell lung cancer (NSCLC) model. The gene discussed is DICER1; the disease is non-small cell lung carcinoma.